1. Academic Validation
  2. The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death

The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death

  • EMBO J. 2000 Jun 15;19(12):2958-68. doi: 10.1093/emboj/19.12.2958.
M Kurokawa 1 K Mitani T Yamagata T Takahashi K Izutsu S Ogawa T Moriguchi E Nishida Y Yazaki H Hirai
Affiliations

Affiliation

  • 1 Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Abstract

Evi-1 encodes a nuclear protein involved in leukemic transformation of hematopoietic cells. Evi-1 possesses two sets of zinc finger motifs separated into two domains, and its characteristics as a transcriptional regulator have been described. Here we show that Evi-1 acts as an inhibitor of c-Jun N-terminal kinase (JNK), a class of mitogen-activated protein kinases implicated in stress responses of cells. Evi-1 physically interacts with JNK, although it does not affect its phosphorylation. This interaction is required for inhibition of JNK. Evi-1 protects cells from stress-induced cell death with dependence on the ability to inhibit JNK. These results reveal a novel function of Evi-1, which provides evidence for inhibition of JNK by a nuclear oncogene product. Evi-1 blocks cell death by selectively inhibiting JNK, thereby contributing to oncogenic transformation of cells.

Figures